Molecular imaging of innate immune cell function in transplant rejection

Circulation

Volumn 119, Issue 14, 2009, Pages 1925-1932

  Christen, Thomas ^a   Nahrendorf, Matthias ^b   Wildgruber, Moritz ^b   Swirski, Filip K ^b   Aikawa, Elena ^b   Waterman, Peter ^b   Shimizu, Koichi ^a   Weissleder, Ralph ^b,c   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Imaging; Inflammation; Leukocytes; Rejection; Transplantation

Indexed keywords

CONTRAST MEDIUM; NANOPARTICLE; PROTEINASE; RECOMBINASE; RECOMBINASE 1; UNCLASSIFIED DRUG; CATHEPSIN; HOMEODOMAIN PROTEIN; RAG 1 PROTEIN; RAG-1 PROTEIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CARDIAC GRAFT REJECTION; CELL FUNCTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME RELEASE; FLOW CYTOMETRY; FLUORESCENCE; GENETICS; GRAFT FAILURE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HISTOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INJECTION; INNATE IMMUNITY; ISOGRAFT; MACROPHAGE; MACROPHAGE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOLECULAR IMAGING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTE; PHAGOCYTOSIS; PREDICTION; PRIORITY JOURNAL; SENSOR; ALLOTRANSPLANTATION; ANIMAL; ENZYMOLOGY; GRAFT REJECTION; HEART MUSCLE; HETEROTOPIC TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CATHEPSINS; FLOW CYTOMETRY; GRAFT REJECTION; HEART TRANSPLANTATION; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYOCARDIUM; NANOPARTICLES; PHAGOCYTES; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 65549171579     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.796888     Document Type: Article

References (26)

1. Mehra MR, Ventura HO, Chambers R, Collins TJ, Ramee SR, Kates MA, Smart FW, Stapleton DD. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 1995;26:1537-1544.
2. Soleimani B, Fu F, Lake P, Shi VC. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy. J Heart Lung Transplant. 2008;27:450-456.
3. Tan CD, Baldwin WM 3rd, Rodriguez ER. Update on cardiac transplantation pathology. Arch Pathol Lab Med. 2007;131:1169-1191.
4. Shimizu K, Libby P, Shubiki R, Sakuma M, Wang Y, Asano K, Mitchell RN, Simon DI. Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection. Circulation. 2008;117:1997-2008.
5. Wyburn KR, Jose MD, Wu H, Atkins RC, Chadban SJ. The role of macrophages in allograft rejection. Transplantation. 2005;80:1641-1647.
6. Nahrendorf M, Sosnovik DE, Waterman P, Swirski FK, Pande AN, Aikawa E, Figueiredo JL, Pittet MJ, Weissleder R. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res. 2007;100:1218 -1225.
7. Sosnovik DE, Nahrendorf M, Deliolanis N, Novikov M, Aikawa E, Josephson L, Rosenzweig A, Weissleder R, Ntziachristos V. Fluorescence tomography and magnetic resonance imaging of myocardial mac- rophage infiltration in infarcted myocardium in vivo. Circulation. 2007; 115:1384-1391.
8. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999;17:375-378.
9. Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci U S A. 2008;105:7387-7392.
10. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med. 2002; 8:757-760.
11. Mahmood U, Tung CH, Bogdanov A Jr, Weissleder R. Near-infrared optical imaging of protease activity for tumor detection. Radiology. 1999; 213:866-870.
12. Furukawa Y, Libby P, Stinn JL, Becker G, Mitchell RN. Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts. Am J Pathol. 2002;160:1077-1087.
13. Shimizu K, Schonbeck U, Mach F, Libby P, Mitchell RN. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol. 2000;165:3506-3518.
14. Akimoto H, McDonald TO, Weyhrich JT, Thomas R, Rothnie CL, Allen MD. Antibody to CD18 reduces neutrophil and T lymphocyte infiltration and vascular cell adhesion molecule-1 expression in cardiac rejection. Transplantation. 1996;61:1610-1617.
15. Stegall MD, Park WD, Kim DY, Covarrubias M, Khair A, Kremers WK. Changes in intragraft gene expression secondary to ischemia reperfusion after cardiac transplantation. Transplantation. 2002;74:924-930.
16. Baskin-Bey ES, Canbay A, Bronk SF, Werneburg N, Guicciardi ME, Nyberg SL, Gores GJ. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2005;288: G396-G402.
17. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, Aikawa E, Libby P, Swirski FK, Weissleder R. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation. 2008;117: 379 -387.
18. Johansson L, Johnsson C, Penno E, Bjornerud A, Ahlstrom H. Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent: experimental study in the rat. Radiology. 2002;225:97-103.
19. Kanno S, Wu YJ, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superpara- magnetic iron oxide particles. Circulation. 2001;104:934-938.
20. Penno E, Johansson L, Ahlstrom H, Johnsson C. Ultrasmall iron oxide particle contrast agent and MRI can be used to monitor the effect of anti-rejection treatment. Transplantation. 2007;84:374-379.
21. Wu YL, Ye Q, Foley LM, Hitchens TK, Sato K, Williams JB, Ho C. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc Natl Acad Sci U S A. 2006; 103:1852-1857.
22. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68:869-877.
23. Penno E, Johnsson C, Johansson L, Ahlstrom H. Macrophage uptake of ultra-small iron oxide particles for magnetic resonance imaging in experimental acute cardiac transplant rejection. Acta Radiol. 2006;47:264-271.
24. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491-2499.
25. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107:2453-2458.
26. Jaffer FA, Vinegoni C, John MC, Aikawa E, Gold HK, Finn AV, Ntziachristos V, Libby P, Weissleder R. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation. 2008;118:1802-1809.